The Chennai-based company reported its highest-ever quarterly revenue of ₹292.66 crores in Q4 FY26, up 18.48% sequentially and 27.04% year-on-year, signalling robust demand recovery in the petrochemicals space. Yet beneath the headline numbers lies a more complex story: operating margins remain under pressure at 8.51%, and the company's profitability continues to be significantly propped up by volatile other income, which constituted 36.46% of profit before tax during the quarter—a concerning dependency that raises questions about the sustainability of core business earnings.
For the full financial year FY26, Manali Petrochemicals delivered consolidated net profit of ₹129.96 crores on revenues of ₹1,022.39 crores, representing a significant turnaround from the previous year's performance. The company's position as the market leader in India's petrochemicals sector—specifically in propylene-based derivatives—provides a strategic moat, though the sector's cyclical nature and margin volatility remain persistent challenges for investors to navigate.
Quarterly Performance Trend: Revenue Growth Outpaces Margin Expansion
| Quarter | Revenue (₹ Cr) | QoQ % | YoY % | Net Profit (₹ Cr) | QoQ % | YoY % | OPM % (Excl OI) | PAT % |
|---|---|---|---|---|---|---|---|---|
| Mar'26 | 292.66 | +18.48% | +27.04% | 29.04 | -57.56% | +168.64% | 8.51% | 9.92% |
| Dec'25 | 247.02 | -0.41% | +25.95% | 68.43 | +277.02% | +1198.48% | 5.66% | 27.70% |
| Sep'25 | 248.04 | +5.70% | +7.74% | 18.15 | +26.57% | +8975.00% | 8.18% | 7.32% |
| Jun'25 | 234.67 | +1.87% | — | 14.34 | +32.65% | — | 9.73% | 6.11% |
| Mar'25 | 230.36 | +17.46% | — | 10.81 | +105.12% | — | 9.13% | 4.69% |
| Dec'24 | 196.12 | -14.81% | — | 5.27 | +2535.00% | — | 6.46% | 2.69% |
| Sep'24 | 230.22 | — | — | 0.20 | — | — | 1.66% | 0.09% |
The quarterly trend table reveals a business in recovery mode but with pronounced volatility. Operating margins excluding other income have oscillated between a low of 1.66% in September 2024 to a high of 9.73% in June 2025, before settling at 8.51% in the latest quarter. This margin instability reflects the petrochemicals sector's inherent exposure to raw material price fluctuations and demand-supply dynamics in derivative products. The exceptional Q3 FY26 profit of ₹68.43 crores was heavily influenced by other income of ₹19.78 crores, which subsequently normalised to ₹6.76 crores in Q4 FY26, explaining much of the sequential profit decline.
Financial Performance Analysis: Strong Topline, Moderate Margins
Manali Petrochemicals delivered its strongest quarterly revenue performance in Q4 FY26 at ₹292.66 crores, representing sequential growth of 18.48% from ₹247.02 crores in Q3 FY26 and year-on-year expansion of 27.04% from ₹230.36 crores in Q4 FY25. This topline momentum reflects improving demand conditions for the company's specialised petrochemical products, particularly propylene oxide and its derivatives, which serve critical applications in polyurethane foams, automotive, construction, and pharmaceutical industries.
Operating profit before depreciation, interest, tax, and other income (PBDIT excluding OI) stood at ₹24.91 crores in Q4 FY26, yielding an operating margin of 8.51%—a sequential improvement from 5.66% in Q3 FY26 but still below the 9.73% achieved in Q1 FY26. The company's gross profit margin for the quarter came in at 15.91%, down sharply from the exceptional 32.85% recorded in Q3 FY26, indicating normalisation of product realisation and raw material cost dynamics. The PAT margin of 9.92% in Q4 FY26, whilst healthy in absolute terms, was significantly lower than the 27.70% achieved in the previous quarter, primarily due to the normalisation of other income.
Employee costs remained relatively stable at ₹17.62 crores in Q4 FY26, down slightly from ₹18.54 crores in the previous quarter, suggesting disciplined workforce management. Interest expenses rose marginally to ₹3.64 crores from ₹3.38 crores quarter-on-quarter, reflecting modest debt levels—the company maintained long-term debt of ₹19.00 crores as of March 2025, making it nearly a net cash company with closing cash of ₹189.00 crores. Depreciation increased to ₹9.49 crores from ₹8.72 crores, in line with ongoing capital expenditure programmes to enhance production capacity.
The tax rate for Q4 FY26 stood at 21.68%, significantly higher than the unusually low 5.51% in Q3 FY26 but more aligned with normalised tax provisions. The company's effective tax rate for the full year FY26 averaged around 13.60%, benefiting from certain tax incentives and deductions available to manufacturing enterprises.
⚠️ Critical Concern: Other Income Dependency
Other income of ₹6.76 crores in Q4 FY26 constituted 36.46% of profit before tax, raising concerns about earnings quality. This metric has been flagged in the company's financial trend analysis as a key negative factor. Whilst other income can include legitimate treasury income and investment gains, such high proportions relative to PBT suggest that core operating profitability remains challenged. Investors should monitor whether the company can sustain profitability purely from its petrochemicals operations without relying on non-operating income streams.
Operational Dynamics: Return Ratios Tell a Sobering Story
Whilst Manali Petrochemicals has demonstrated revenue recovery, the company's return ratios paint a more sobering picture of operational efficiency and capital productivity. The return on capital employed (ROCE) for the half-year period stood at 6.22%—flagged as the highest in recent periods but still modest in absolute terms. The company's average ROCE over a longer timeframe is reported at 32.80%, suggesting that current performance remains well below historical peaks achieved during more favourable industry cycles.
Return on equity (ROE) of 4.52% in the latest period reflects weak shareholder returns, though the average ROE of 14.95% over time indicates better historical performance. It is important to emphasise that higher ROE signifies superior capital efficiency and profitability—the current ROE of 4.52% is therefore a concern requiring attention, particularly given that the company's net worth stood at ₹1,094.45 crores as of March 2025. This translates to a book value per share of ₹63.61, almost exactly in line with the current market price of ₹63.80, indicating that the market is ascribing minimal premium to the company's future earnings potential.
The company's balance sheet reveals a conservative financial structure. With shareholder funds of ₹1,094.45 crores, long-term debt of just ₹19.00 crores, and cash reserves of ₹189.00 crores as of March 2025, Manali Petrochemicals operates with a negative net debt-to-equity ratio of -0.18, effectively making it a net cash company. This financial prudence provides a cushion during cyclical downturns but also raises questions about whether the company is optimally deploying its capital to generate returns. Fixed assets stood at ₹512.70 crores, with current assets of ₹691.75 crores, indicating a healthy liquidity position.
Balance Sheet Strength: Net Cash Position
Manali Petrochemicals' debt-to-EBITDA ratio of 1.18 and net debt-to-equity of -0.18 position it as one of the more financially stable players in the petrochemicals sector. The company's EBIT-to-interest coverage ratio of 19.86 times (on average) demonstrates comfortable debt servicing capability, though with minimal debt, this metric is less relevant. The company's sales-to-capital-employed ratio of 1.08 suggests moderate asset turnover, indicating room for improvement in sweating existing assets more efficiently.
Working capital management showed some deterioration, with the debtors turnover ratio at half-year falling to 5.68 times—flagged as the lowest in recent periods. This suggests that the company is taking longer to collect receivables, potentially indicating either looser credit terms extended to customers or slower payment cycles in the industry. The debt-to-equity ratio at half-year reached 0.14 times, the highest in recent periods, though still at very comfortable levels.
Petrochemicals Sector Context: Navigating Cyclical Headwinds
Manali Petrochemicals operates in India's petrochemicals sector, which has faced significant headwinds over the past two years due to global oversupply conditions, subdued demand from downstream industries, and volatile crude oil and feedstock prices. The company's one-year stock return of 12.42% significantly outperformed the broader petrochemicals sector, which delivered a negative return of -23.79% over the same period—an outperformance of 36.21 percentage points. This relative strength suggests that Manali's specialised product portfolio and market leadership position have provided some insulation from broader sector weakness.
The company's five-year sales growth of just 1.51% and five-year EBIT growth of -22.31% reflect the challenging operating environment that has persisted in the petrochemicals space. The sector has been characterised by margin compression due to increased global capacity additions, particularly from Middle Eastern and Chinese producers, which have pressured product realisations. Manali's focus on import-substitute chemicals provides some pricing power, but the company is not immune to international price benchmarks.
As India's only domestic manufacturer of Propylene Glycol and the country's first and largest producer of Propylene Oxide, Manali Petrochemicals enjoys a unique competitive position. These products serve as critical inputs for polyurethane foams, antifreeze, cosmetics, pharmaceuticals, and various industrial applications. The company's integrated production capabilities—manufacturing both propylene oxide and its downstream derivatives—provide vertical integration benefits and the ability to optimise product mix based on margin dynamics.
| Company | P/E (TTM) | P/BV | ROE % | Debt/Equity | Div Yield % |
|---|---|---|---|---|---|
| Manali Petrochem | 14.38 | 0.84 | 14.95% | -0.18 | 0.90% |
| Supreme Petroch. | 38.41 | 5.83 | 24.10% | -0.18 | 1.45% |
| Rain Industries | 17.15 | 0.69 | 5.43% | 1.11 | 0.65% |
| DCW | 28.62 | 1.28 | 7.27% | 0.08 | 0.43% |
| T N Petro Prod. | 8.80 | 0.79 | 11.19% | 0.12 | 1.34% |
| Agarwal Indl. | 10.48 | 0.93 | 20.42% | 0.51 | 0.81% |
Relative to its peer group, Manali Petrochemicals trades at a P/E ratio of 14.38 times, below the peer average of approximately 21 times, suggesting a valuation discount. The company's price-to-book value of 0.84 times is also amongst the lowest in the peer set, with only Rain Industries trading at a lower P/BV of 0.69 times. This valuation discount may reflect market concerns about the company's modest ROE of 14.95% (average), which trails peers like Supreme Petrochemicals (24.10% ROE) and Agarwal Industrial (20.42% ROE).
Manali's net cash position (debt-to-equity of -0.18) matches Supreme Petrochemicals and is superior to Rain Industries (debt-to-equity of 1.11), providing financial flexibility. However, the company's dividend yield of 0.90% is below the peer average, with Supreme Petrochemicals offering a more attractive 1.45% yield. The company's latest dividend of ₹0.50 per share (ex-date September 8, 2025) represents a dividend payout ratio of 67.18%, indicating a shareholder-friendly policy despite modest profitability.
Valuation Analysis: Trading at Book Value with Limited Upside
At the current market price of ₹63.80, Manali Petrochemicals trades at a P/E ratio of 14.38 times trailing twelve-month earnings and a price-to-book value of 0.84 times. The company's valuation has been assessed as "Very Expensive" by proprietary grading systems, having oscillated between "Expensive" and "Very Expensive" classifications over recent months. This assessment appears counterintuitive given the low absolute valuation multiples, but likely reflects the company's weak earnings trajectory and modest return ratios relative to its historical performance.
The stock's EV/EBITDA multiple of 9.62 times and EV/EBIT of 16.09 times suggest that the market is pricing in limited earnings growth potential. The company's PEG ratio of 0.06 appears extremely attractive on the surface, but this metric is distorted by the negative five-year EBIT growth rate of -22.31%, rendering the PEG ratio less meaningful as a valuation tool in this context. The EV-to-sales ratio of 0.78 times and EV-to-capital-employed ratio of 0.81 times indicate that the company is trading below its asset base, which could represent value for patient investors betting on a cyclical recovery.
The company's 52-week price range of ₹39.15 to ₹81.00 illustrates significant volatility, with the current price sitting 21.23% below the 52-week high and 62.96% above the 52-week low. The stock has demonstrated resilience in recent months, trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating positive near-term momentum. However, the technical trend is classified as "Sideways" as of May 18, 2026, suggesting a lack of clear directional conviction.
Given the company's book value per share of ₹63.61 and current market price of ₹63.80, the stock is trading almost exactly at book value. For a company generating a return on equity of only 4.52% in the latest period, this valuation appears fair but offers limited upside unless the company can demonstrate sustained improvement in profitability and return ratios. A fair value estimate would place the stock in the ₹65-70 range, implying modest upside of 2-10% from current levels, contingent on margin expansion and stabilisation of other income.
Shareholding Pattern: Stable Promoter Base, Minimal Institutional Interest
| Quarter | Promoter % | Change | FII % | Change | MF % | DII % | Non-Inst % |
|---|---|---|---|---|---|---|---|
| Mar'26 | 44.86% | 0.00% | 0.37% | +0.08% | 0.01% | 0.00% | 54.76% |
| Dec'25 | 44.86% | 0.00% | 0.29% | -0.15% | 0.01% | 0.00% | 54.83% |
| Sep'25 | 44.86% | 0.00% | 0.44% | -0.01% | 0.01% | 0.00% | 54.69% |
| Jun'25 | 44.86% | 0.00% | 0.45% | -0.21% | 0.01% | 0.00% | 54.67% |
| Mar'25 | 44.86% | — | 0.66% | — | 0.01% | 0.00% | 54.47% |
The shareholding pattern of Manali Petrochemicals has remained remarkably stable over the past five quarters, with promoter holding steady at 44.86%. The promoter group is led by Sidd Life Sciences Private Limited (38.28%), Tamil Nadu Industrial Development Corporation Limited (6.52%), and several smaller entities. Critically, there is zero promoter pledging, which is a positive signal of financial stability and confidence in the business.
Foreign institutional investor (FII) holding stands at a minuscule 0.37% as of March 2026, showing a marginal uptick of 0.08% from the previous quarter after declining from 0.66% in March 2025. The limited and declining FII interest suggests that international investors remain cautious about the company's prospects, likely due to concerns about earnings volatility and modest return ratios. Mutual fund holdings are negligible at 0.01%, with only four mutual funds holding positions, whilst insurance companies have zero exposure. Overall institutional holdings stand at just 0.38%, indicating that Manali Petrochemicals remains largely off the radar of institutional investors.
The non-institutional shareholding of 54.76% comprises retail investors and non-institutional entities, providing a stable shareholder base but also limiting the stock's liquidity and institutional sponsorship. The absence of meaningful institutional buying suggests that the stock will need to demonstrate consistent earnings improvement and margin expansion before attracting broader institutional interest.
Stock Performance: Outperforming Sector, Underperforming Market
| Period | Stock Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Day | +15.08% | +0.58% | +14.50% |
| 1 Week | +14.21% | +0.51% | +13.70% |
| 1 Month | +15.83% | -3.69% | +19.52% |
| 3 Month | +14.05% | -8.69% | +22.74% |
| 6 Month | -2.57% | -11.28% | +8.71% |
| YTD | +1.16% | -11.27% | +12.43% |
| 1 Year | +12.42% | -6.59% | +19.01% |
| 2 Years | -18.29% | +1.88% | -20.17% |
| 3 Years | -10.74% | +22.04% | -32.78% |
| 5 Years | -21.28% | +49.62% | -70.90% |
Manali Petrochemicals has delivered strong near-term returns, with the stock surging 15.08% on the results announcement day (May 22, 2026) and generating positive alpha of 14.50% versus the Sensex. Over the past month, the stock has returned 15.83% compared to the Sensex's decline of 3.69%, resulting in alpha of 19.52%. The three-month return of 14.05% significantly outpaced the Sensex's decline of 8.69%, delivering alpha of 22.74%. This near-term outperformance reflects improving sentiment around the company's earnings recovery and the broader market's defensive positioning amid broader market weakness.
However, the longer-term picture is less flattering. Over two years, the stock has declined 18.29% compared to the Sensex's gain of 1.88%, resulting in negative alpha of 20.17%. The three-year return of -10.74% compares unfavourably to the Sensex's gain of 22.04%, whilst the five-year return of -21.28% significantly trails the Sensex's advance of 49.62%. These longer-term underperformance metrics reflect the structural challenges in the petrochemicals sector and the company's inability to generate consistent earnings growth over extended periods.
The stock's one-year return of 12.42% substantially outperformed the petrochemicals sector's decline of 23.79%, suggesting that Manali's specialised product portfolio and market leadership position have provided relative resilience. The stock's beta of 1.12 indicates higher volatility than the broader market, with annualised volatility of 43.90% classifying it as a high-risk, high-return investment. The positive Sharpe ratio over the past year suggests that the returns have adequately compensated for the elevated risk, though investors should be cognisant of the significant price swings inherent in the stock.
Investment Thesis: Quality Concerns Limit Conviction
Manali Petrochemicals' investment thesis rests on several pillars: its unique position as India's sole domestic manufacturer of Propylene Glycol and the country's largest producer of Propylene Oxide, a conservative balance sheet with net cash position, improving revenue trajectory, and valuation at book value. However, these positives are offset by persistent concerns about margin sustainability, earnings quality due to high other income dependency, modest return ratios, and weak long-term growth metrics.
The company's overall quality grade is assessed as "Average," reflecting long-term financial performance that has been acceptable but not exceptional. Key quality factors include an average ROCE of 32.80% (historically strong but currently at just 6.22%), average ROE of 14.95% (currently at a weak 4.52%), five-year sales growth of only 1.51%, and five-year EBIT decline of 22.31%. On the positive side, the company maintains zero promoter pledging, operates with minimal debt (debt-to-EBITDA of 1.18), and has consistently paid dividends (67.18% payout ratio).
The company's proprietary Mojo score stands at 64 out of 100, placing it in the "HOLD" category (scores of 50-70). The score reflects a mix of positive near-term financial trends (quarterly performance improving) and attractive valuation (trading at book value), offset by average quality metrics and sideways technical trends. The financial trend is classified as "Positive" based on factors such as highest quarterly revenue of ₹292.66 crores, highest half-yearly ROCE of 6.22%, and 91.69% growth in PAT over the latest six months. However, negative factors include rising interest costs, declining quarterly PAT versus the four-quarter average, and concerning levels of other income as a percentage of PBT.
Key Strengths & Risk Factors
KEY STRENGTHS ✓
- Market Leadership: India's only domestic manufacturer of Propylene Glycol and largest producer of Propylene Oxide provides pricing power and import substitution benefits
- Strong Balance Sheet: Net cash position with debt-to-equity of -0.18, zero promoter pledging, and cash reserves of ₹189 crores provide financial flexibility
- Revenue Recovery: Q4 FY26 revenue of ₹292.66 crores represents highest-ever quarterly sales, up 27.04% YoY, indicating demand improvement
- Attractive Valuation: Trading at 0.84 times book value and 14.38 times P/E offers value for patient investors betting on cyclical recovery
- Consistent Dividend Policy: Dividend payout ratio of 67.18% demonstrates shareholder-friendly capital allocation despite modest profitability
- Sector Outperformance: One-year return of 12.42% significantly outpaced petrochemicals sector decline of 23.79%, showing relative resilience
KEY CONCERNS ⚠
- Earnings Quality Issues: Other income constituting 36.46% of Q4 FY26 PBT raises serious concerns about sustainability of core operating profitability
- Weak Return Ratios: Current ROE of 4.52% and ROCE of 6.22% are significantly below historical averages and peer benchmarks, indicating poor capital efficiency
- Margin Volatility: Operating margins oscillating between 1.66% and 9.73% over recent quarters reflect unstable pricing power and cost management challenges
- Negative Long-Term Growth: Five-year EBIT decline of 22.31% and sales growth of just 1.51% highlight structural profitability challenges
- Minimal Institutional Interest: FII holding of just 0.37% and total institutional ownership of 0.38% limit liquidity and institutional sponsorship
- Working Capital Deterioration: Debtors turnover ratio declining to 5.68 times suggests lengthening receivables cycle and potential cash flow pressures
- Cyclical Sector Exposure: Petrochemicals remain highly cyclical with vulnerability to global overcapacity, crude oil volatility, and demand fluctuations
Outlook: What to Watch
POSITIVE CATALYSTS
- Sustained revenue growth above ₹280 crores per quarter with stabilising margins above 9%
- Reduction in other income dependency to below 20% of PBT, indicating stronger core profitability
- Improvement in ROE above 10% and ROCE above 15% on a sustained basis
- Increased institutional buying (FII/MF holdings rising above 2-3%) signalling improved confidence
- Capacity expansion announcements or new product launches leveraging existing infrastructure
RED FLAGS
- Operating margins falling below 7% or PAT margins declining below 5% in any quarter
- Other income exceeding 40% of PBT or showing increasing volatility quarter-to-quarter
- Working capital deterioration with debtors days extending beyond current levels
- Promoter stake reduction or any pledging of shares
- Inability to maintain positive cash flows from operations over consecutive quarters
The Verdict: Hold with Cautious Optimism
Score: 64/100
For Fresh Investors: Not recommended for fresh buying at current levels. Whilst the stock trades at attractive valuation (0.84 times book value), concerns about earnings quality, weak return ratios, and margin sustainability warrant caution. Better entry points may emerge if the stock corrects towards ₹55-58 levels. Investors seeking exposure to the petrochemicals recovery should wait for sustained improvement in operating margins and reduction in other income dependency before initiating positions.
For Existing Holders: Continue to hold with a 12-18 month investment horizon. The company's market leadership position, improving revenue trajectory, and strong balance sheet provide downside protection. However, set a stop-loss at ₹55 (book value minus 10%) and monitor quarterly results closely for margin trends and earnings quality. Consider partial profit booking if the stock approaches ₹75-80 levels without corresponding improvement in return ratios.
Fair Value Estimate: ₹68 (6.5% upside from current levels), contingent on the company sustaining operating margins above 9%, reducing other income dependency, and demonstrating consistent quarterly profitability. Significant upside potential exists if the petrochemicals cycle turns decisively positive, but current fundamentals justify only modest premium to book value.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
